Trial intelligence / Profile preview

Alendronate for Osteoporosis in Adult Cystic Fibrosis Patients

NCT00157690Phase 4Completed

Sponsor
McMaster University
Start
Dec 2003
Primary completion
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in osteoporosis and osteopenia comparing Alendronate with Placebo (2 arms). Primary endpoint: Lumbar Spine Bone Mineral Density at 12 months. Started Dec 2003; status: completed.

02

Drugs

alendronate
03

Conditions

osteoporosisosteopenia

Beyond the preview

Go deeper on NCT00157690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00157690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call